Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Fertilization-Coupled Sperm Nuclear Fusion is Required for Normal Endosperm Nuclear Proliferation.

Maruyama D, Higashiyama T, Endo T, Nishikawa SI.

Plant Cell Physiol. 2019 Aug 14. pii: pcz158. doi: 10.1093/pcp/pcz158. [Epub ahead of print]

PMID:
31410484
2.

Migration of lipiodol into lateral ventricles after embolization of cerebral arteriovenous malformation: a case report.

Murakami M, Fujiwara G, Maruyama D, Komaru Y, Murakami N.

Br J Neurosurg. 2019 Jul 31:1-4. doi: 10.1080/02688697.2019.1648755. [Epub ahead of print]

PMID:
31364414
3.

EBV-encoded RNA1-positive cells in the bone marrow specimens of patients with EBV-negative lymphomas and sarcomas.

Ito Y, Makita S, Maeshima AM, Hatta S, Yuda S, Suzuki T, Fukuhara S, Munakata W, Taniguchi H, Suzuki T, Maruyama D, Izutsu K.

Pathol Int. 2019 Jul;69(7):392-397. doi: 10.1111/pin.12825. Epub 2019 Jul 21.

PMID:
31328350
4.

Final analysis of a phase II study of ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma.

Maruyama D, Nagai H, Fukuhara N, Kitano T, Ishikawa T, Nishikawa T.

J Clin Exp Hematop. 2019;59(2):98-100. doi: 10.3960/jslrt.19006. No abstract available.

5.

Bone marrow involvement by monomorphic epitheliotropic intestinal T-cell lymphoma.

Ikeda C, Maruyama D, Oka H, Fujino T, Maeshima AM, Matsushita H.

Br J Haematol. 2019 Jun 25. doi: 10.1111/bjh.16073. [Epub ahead of print] No abstract available.

PMID:
31240703
6.

Multiple myeloma with IGH-FGFR3 rearrangement progressing as testicular plasmacytoma during carfilzomib treatment.

Nakamura N, Maruyama D, Maeshima AM, Saito Y, Fujino T, Ito Y, Hatta S, Makita S, Fukuhara S, Munakata W, Suzuki T, Fujimoto H, Izutsu K.

Ann Hematol. 2019 Jun 25. doi: 10.1007/s00277-019-03743-6. [Epub ahead of print] No abstract available.

PMID:
31240468
7.

Clinicopathological characteristics of diffuse large B-cell lymphoma involving small and large intestines: an analysis of 126 patients.

Maeshima AM, Taniguchi H, Ito Y, Hatta S, Suzuki T, Yuda S, Makita S, Fukuhara S, Munakata W, Suzuki T, Maruyama D, Izutsu K.

Int J Hematol. 2019 Sep;110(3):340-346. doi: 10.1007/s12185-019-02687-x. Epub 2019 Jun 11.

PMID:
31187439
8.

Possibility of a risk-adapted treatment strategy for untreated aggressive adult T-cell leukaemia-lymphoma (ATL) based on the ATL prognostic index: a supplementary analysis of the JCOG9801.

Toyoda K, Tsukasaki K, Machida R, Kadota T, Fukushima T, Ishitsuka K, Maruyama D, Nagai H.

Br J Haematol. 2019 Aug;186(3):440-447. doi: 10.1111/bjh.15950. Epub 2019 May 16.

PMID:
31099033
9.

Draft Genome Sequence of Mycolicibacterium sp. Strain NCC-Tsukiji, Isolated from Blood Culture of a Patient with Malignant Lymphoma.

Fukano H, Yoshida M, Shouji M, Hatta S, Maruyama D, Izutsu K, Shiotsuka M, Ogura Y, Hayashi T, Hasegawa N, Iwata S, Hoshino Y.

Microbiol Resour Announc. 2019 Apr 4;8(14). pii: e01575-18. doi: 10.1128/MRA.01575-18.

10.

Mucosa-associated lymphoid tissue lymphoma with t(11;18)(q21;q21) translocation: long-term follow-up results.

Toyoda K, Maeshima AM, Nomoto J, Suzuki T, Yuda S, Yamauchi N, Taniguchi H, Makita S, Fukuhara S, Munakata W, Maruyama D, Tobinai K, Kobayashi Y.

Ann Hematol. 2019 Jul;98(7):1675-1687. doi: 10.1007/s00277-019-03671-5. Epub 2019 Mar 28.

PMID:
30923996
11.

Multi-institutional comparison of secondary check of treatment planning using computer-based independent dose calculation for non-C-arm linear accelerators.

Tachibana H, Uchida Y, Miyakawa R, Yamashita M, Sato A, Kito S, Maruyama D, Noda S, Kojima T, Fukuma H, Shirata R, Okamoto H, Nakamura M, Takada Y, Nagata H, Hayashi N, Takahashi R, Kawai D, Itano M.

Phys Med. 2018 Dec;56:58-65. doi: 10.1016/j.ejmp.2018.11.011. Epub 2018 Nov 23.

PMID:
30527090
12.

[Treatment strategy for high-grade B-cell lymphoma].

Maruyama D.

Rinsho Ketsueki. 2018;59(10):2109-2116. doi: 10.11406/rinketsu.59.2109. Review. Japanese.

PMID:
30305516
13.

Multimodal Interventional Treatment and Outcomes for Unruptured Arteriovenous Malformations.

Maruyama D, Satow T, Kataoka H, Mori H, Hamano E, Orita Y, Eguchi S, Takahashi JC.

Acta Neurochir Suppl. 2018;129:115-120. doi: 10.1007/978-3-319-73739-3_17.

PMID:
30171323
14.

Weekly carfilzomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma: A phase 1 and PK/PD trial.

Maruyama D, Tobinai K, Chou T, Taniwaki M, Shumiya Y, Iida S.

Cancer Sci. 2018 Oct;109(10):3245-3252. doi: 10.1111/cas.13753. Epub 2018 Sep 5.

15.

Correction to: Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma.

Maruyama D, Tsukasaki K, Uchida T, Maeda Y, Shibayama H, Nagai H, Kurosawa M, Suehiro Y, Hatake K, Ando K, Yoshida I, Hidaka M, Murayama T, Okitsu Y, Tsukamoto N, Taniwaki M, Suzumiya J, Tamura K, Yamauchi T, Ueda R, Tobinai K.

Ann Hematol. 2018 Dec;97(12):2529-2530. doi: 10.1007/s00277-018-3455-x.

PMID:
30054705
16.

Neurosurgical Management and Outcomes of Cerebrovascular Disease in Pediatric Patients with Heart Disease.

Maruyama D, Kataoka H, Satow T, Mori H, Ito Y, Hamano E, Tanaka S, Ishiguro T, Chikuie H, Takahashi JC.

Neurol Med Chir (Tokyo). 2018 Aug 15;58(8):334-340. doi: 10.2176/nmc.st.2018-0034. Epub 2018 Jul 12.

17.

Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma.

Maruyama D, Tsukasaki K, Uchida T, Maeda Y, Shibayama H, Nagai H, Kurosawa M, Suehiro Y, Hatake K, Ando K, Yoshida I, Hidaka M, Murayama T, Okitsu Y, Tsukamoto N, Taniwaki M, Suzumiya J, Tamura K, Yamauchi T, Ueda R, Tobinai K.

Ann Hematol. 2019 Jan;98(1):131-142. doi: 10.1007/s00277-018-3418-2. Epub 2018 Jul 5. Erratum in: Ann Hematol. 2018 Dec;97(12):2529-2530.

18.

R-High-CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY.

Ogura M, Yamamoto K, Morishima Y, Wakabayashi M, Tobinai K, Ando K, Uike N, Kurosawa M, Gomyo H, Taniwaki M, Nosaka K, Tsukamoto N, Shimoyama T, Fukuhara N, Yakushijin Y, Ohnishi K, Miyazaki K, Sawada K, Takayama N, Hanamura I, Nagai H, Kobayashi H, Usuki K, Kobayashi N, Ohyashiki K, Utsumi T, Kumagai K, Maruyama D, Ohmachi K, Matsuno Y, Nakamura S, Hotta T, Tsukasaki K; Japan Clinical Oncology Group- Lymphoma Study Group (JCOG-LSG).

Cancer Sci. 2018 Sep;109(9):2830-2840. doi: 10.1111/cas.13719. Epub 2018 Jul 28.

19.

Phase III study of watchful waiting vs. rituximab as first-line treatment in advanced stage follicular lymphoma with low tumour burden (JCOG1411, FLORA study).

Miyamoto K, Fukuhara N, Maruyama D, Shibata T, Nakamura K, Ishizawa K, Tsukasaki K, Nagai H; Lymphoma Study Group of the Japan Clinical Oncology Group.

Jpn J Clin Oncol. 2018 Aug 1;48(8):777-780. doi: 10.1093/jjco/hyy085.

PMID:
29901705
20.

Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review.

Makita S, Maeshima AM, Maruyama D, Izutsu K, Tobinai K.

Onco Targets Ther. 2018 Apr 20;11:2287-2293. doi: 10.2147/OTT.S140756. eCollection 2018. Review.

21.

Successful full-dose DeVIC therapy in a patient with advanced-stage extranodal natural killer/T-cell lymphoma refractory to L-asparaginase.

Watanabe J, Makita S, Ito Y, Hatta S, Suzuki T, Yuda S, Maeshima AM, Fukuhara S, Munakata W, Suzuki T, Maruyama D, Kim SW, Izutsu K.

Ann Hematol. 2018 Sep;97(9):1739-1740. doi: 10.1007/s00277-018-3335-4. Epub 2018 Apr 16. No abstract available.

PMID:
29663028
22.

CD3+ CD56+ EBER1+ atypical extraosseous plasmacytoma of the nasal cavity.

Ando Y, Maeshima AM, Fukuhara S, Makita S, Munakata W, Suzuki T, Maruyama D, Taniguchi H, Izutsu K.

Int J Hematol. 2018 Sep;108(3):344-347. doi: 10.1007/s12185-018-2438-y. Epub 2018 Mar 23.

PMID:
29572766
23.

Paraneoplastic Pemphigus Associated with B-cell Chronic Lymphocytic Leukemia Treated with Ibrutinib and Rituximab.

Ito Y, Makita S, Maeshima AM, Hatta S, Suzuki T, Yuda S, Fukuhara S, Munakata W, Suzuki T, Maruyama D, Izutsu K.

Intern Med. 2018 Aug 15;57(16):2395-2398. doi: 10.2169/internalmedicine.0578-17. Epub 2018 Mar 9.

24.

Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma.

Iida S, Wakabayashi M, Tsukasaki K, Miyamoto K, Maruyama D, Yamamoto K, Takatsuka Y, Kusumoto S, Kuroda J, Ando K, Kikukawa Y, Masaki Y, Kobayashi M, Hanamura I, Asai H, Nagai H, Shimada K, Tsukamoto N, Inoue Y, Tobinai K.

Cancer Sci. 2018 May;109(5):1552-1561. doi: 10.1111/cas.13550. Epub 2018 Apr 17.

25.

Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma.

Tanaka Y, Maeshima AM, Nomoto J, Makita S, Fukuhara S, Munakata W, Maruyama D, Tobinai K, Kobayashi Y.

Eur J Haematol. 2018 May;100(5):511-517. doi: 10.1111/ejh.13033. Epub 2018 Mar 1.

PMID:
29377256
26.

E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma: A phase I study.

Ohmachi K, Ando K, Ogura M, Uchida T, Tobinai K, Maruyama D, Namiki M, Nakanishi T.

Cancer Sci. 2018 Mar;109(3):794-802. doi: 10.1111/cas.13513. Epub 2018 Feb 26.

27.

Atypical radiological presentation of pulmonary invasion of diffuse large B-cell lymphoma mimicking Pneumocystis jiroveci pneumonia.

Higashiyama RI, Makita S, Maeshima AM, Maruyama D.

Jpn J Clin Oncol. 2018 Mar 1;48(3):298-299. doi: 10.1093/jjco/hyx194. No abstract available.

PMID:
29351631
28.

Functional network stability and average minimal distance - A framework to rapidly assess dynamics of functional network representations.

Wu J, Skilling QM, Maruyama D, Li C, Ognjanovski N, Aton S, Zochowski M.

J Neurosci Methods. 2018 Feb 15;296:69-83. doi: 10.1016/j.jneumeth.2017.12.021. Epub 2017 Dec 30.

29.

Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma.

Saito H, Maruyama D, Maeshima AM, Makita S, Kitahara H, Miyamoto K, Fukuhara S, Munakata W, Suzuki T, Kobayashi Y, Taniguchi H, Tobinai K.

Blood Cancer J. 2017 Nov 3;7(11):e620. doi: 10.1038/bcj.2017.100.

30.

Double-Expressor Lymphoma Is Associated with Poor Outcomes after Allogeneic Hematopoietic Cell Transplantation.

Kawashima I, Inamoto Y, Maeshima AM, Nomoto J, Tajima K, Honda T, Shichijo T, Kawajiri A, Takemura T, Onishi A, Ito A, Tanaka T, Fuji S, Kurosawa S, Kim SW, Maruyama D, Tobinai K, Kobayashi Y, Fukuda T.

Biol Blood Marrow Transplant. 2018 Feb;24(2):294-300. doi: 10.1016/j.bbmt.2017.10.013. Epub 2017 Oct 14.

31.

Live-Cell Imaging of F-Actin Dynamics During Fertilization in Arabidopsis thaliana.

Susaki D, Maruyama D, Yelagandula R, Berger F, Kawashima T.

Methods Mol Biol. 2017;1669:47-54. doi: 10.1007/978-1-4939-7286-9_4.

PMID:
28936648
32.

Distribution of malignant lymphomas in the anterior mediastinum: a single-institution study of 76 cases in Japan, 1997-2016.

Maeshima AM, Taniguchi H, Suzuki T, Yuda S, Toyoda K, Yamauchi N, Makita S, Fukuhara S, Munakata W, Maruyama D, Kobayashi Y, Tobinai K.

Int J Hematol. 2017 Nov;106(5):675-680. doi: 10.1007/s12185-017-2331-0. Epub 2017 Sep 18.

PMID:
28921451
33.

Malignant lymphoma in adolescents and young adults: from the viewpoint of physicians.

Maruyama D.

Rinsho Ketsueki. 2017;58(8):1060-1068. doi: 10.11406/rinketsu.58.1060. Japanese.

PMID:
28883270
34.

A pharmacological study of Arabidopsis cell fusion between the persistent synergid and endosperm.

Motomura K, Kawashima T, Berger F, Kinoshita T, Higashiyama T, Maruyama D.

J Cell Sci. 2018 Jan 29;131(2). pii: jcs204123. doi: 10.1242/jcs.204123.

35.

Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T-cell lymphoma.

Maruyama D, Nagai H, Maeda Y, Nakane T, Shimoyama T, Nakazato T, Sakai R, Ishikawa T, Izutsu K, Ueda R, Tobinai K.

Cancer Sci. 2017 Oct;108(10):2061-2068. doi: 10.1111/cas.13340. Epub 2017 Sep 4.

36.

Effective Intraluminal Shunt in Carotid Endarterectomy for Carotid Artery Near Occlusion: Technical Report.

Kawamura Y, Maruyama D, Akagi Y, Iihara K.

World Neurosurg. 2017 Oct;106:813-818. doi: 10.1016/j.wneu.2017.07.078. Epub 2017 Jul 21.

PMID:
28739521
37.

Erratum: Parvalbumin-expressing interneurons coordinate hippocampal network dynamics required for memory consolidation.

Ognjanovski N, Schaeffer S, Wu J, Mofakham S, Maruyama D, Zochowski M, Aton SJ.

Nat Commun. 2017 Jul 6;8:16120. doi: 10.1038/ncomms16120.

38.

Romidepsin in Japanese patients with relapsed or refractory peripheral T-cell lymphoma: a phase I/II and pharmacokinetics study.

Maruyama D, Tobinai K, Ogura M, Uchida T, Hatake K, Taniwaki M, Ando K, Tsukasaki K, Ishida T, Kobayashi N, Ishizawa K, Tatsumi Y, Kato K, Kiguchi T, Ikezoe T, Laille E, Ro T, Tamakoshi H, Sakurai S, Ohtsu T.

Int J Hematol. 2017 Nov;106(5):655-665. doi: 10.1007/s12185-017-2286-1. Epub 2017 Jun 29.

PMID:
28664499
39.

Comparison of clinicopathologic characteristics of gastric follicular lymphomas and duodenal follicular lymphomas.

Maeshima AM, Taniguchi H, Suzuki T, Yuda S, Toyoda K, Yamauchi N, Makita S, Fukuhara S, Munakata W, Maruyama D, Kobayashi Y, Saito Y, Tobinai K.

Hum Pathol. 2017 Jul;65:201-208. doi: 10.1016/j.humpath.2017.04.025. Epub 2017 May 10.

PMID:
28504205
40.

Correlation between reduction in microvascular transit time after superficial temporal artery-middle cerebral artery bypass surgery for moyamoya disease and the development of postoperative hyperperfusion syndrome.

Yang T, Higashino Y, Kataoka H, Hamano E, Maruyama D, Iihara K, Takahashi JC.

J Neurosurg. 2018 May;128(5):1304-1310. doi: 10.3171/2016.11.JNS162403. Epub 2017 May 12.

PMID:
28498060
41.

RETINOBLASTOMA RELATED1 mediates germline entry in Arabidopsis.

Zhao X, Bramsiepe J, Van Durme M, Komaki S, Prusicki MA, Maruyama D, Forner J, Medzihradszky A, Wijnker E, Harashima H, Lu Y, Schmidt A, Guthörl D, Logroño RS, Guan Y, Pochon G, Grossniklaus U, Laux T, Higashiyama T, Lohmann JU, Nowack MK, Schnittger A.

Science. 2017 Apr 28;356(6336). pii: eaaf6532. doi: 10.1126/science.aaf6532.

PMID:
28450583
42.

Azacitidine-induced acute lung injury in a patient with therapy-related myelodysplastic syndrome.

Makita S, Munakata W, Watabe D, Maeshima AM, Taniguchi H, Toyoda K, Yamauchi N, Fukuhara S, Maruyama D, Kobayashi Y, Tobinai K.

J Int Med Res. 2017 Apr;45(2):886-893. doi: 10.1177/0300060517698331. Epub 2017 Mar 16.

43.

Parvalbumin-expressing interneurons coordinate hippocampal network dynamics required for memory consolidation.

Ognjanovski N, Schaeffer S, Wu J, Mofakham S, Maruyama D, Zochowski M, Aton SJ.

Nat Commun. 2017 Apr 6;8:15039. doi: 10.1038/ncomms15039. Erratum in: Nat Commun. 2017 Jul 06;8:16120.

44.

Spatiotemporal deep imaging of syncytium induced by the soybean cyst nematode Heterodera glycines.

Ohtsu M, Sato Y, Kurihara D, Suzaki T, Kawaguchi M, Maruyama D, Higashiyama T.

Protoplasma. 2017 Nov;254(6):2107-2115. doi: 10.1007/s00709-017-1105-0. Epub 2017 Mar 25.

PMID:
28343256
45.

Basic Study on Visibility and Water Equivalency of a New Colorless Transparent Bolus for Electron Radiotherapy.

Maruyama D, Yamazaki S, Honda E, Suzuki E, Hommatsu K, Oshiba R, Sato N.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2017;73(3):194-201. doi: 10.6009/jjrt.2017_JSRT_73.3.194. Japanese.

46.

Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma.

Maruyama D, Hatake K, Kinoshita T, Fukuhara N, Choi I, Taniwaki M, Ando K, Terui Y, Higuchi Y, Onishi Y, Abe Y, Kobayashi T, Shirasugi Y, Tobinai K.

Cancer Sci. 2017 May;108(5):1007-1012. doi: 10.1111/cas.13230. Epub 2017 May 19.

47.

Understanding spatial and temporal patterning of astrocyte calcium transients via interactions between network transport and extracellular diffusion.

Shtrahman E, Maruyama D, Olariu E, Fink CG, Zochowski M.

Phys Biol. 2017 Jan 27;14(1):016001. doi: 10.1088/1478-3975/aa5565.

48.

Immune-checkpoint inhibitors in hematologic malignancies.

Maruyama D.

Rinsho Ketsueki. 2016;57(11):2381-2387. Japanese.

PMID:
27941289
49.

Long-term follow-up results of a phase I/II study of melphalan, prednisolone and bortezomib in Japanese transplant-ineligible multiple myeloma patients (JPN-102).

Ogiya D, Shibayama H, Nakatani E, Ando K, Suzuki K, Kuroda Y, Uchida T, Maruyama D, Matsumoto M, Matsue K, Iida S, Terui Y, Ri M, Chou T, Aotsuka N, Tabata S, Konishi J, Ohashi K, Shinagawa A, Sugiura I, Kuroda J, Miyamoto T, Ogura M, Tobinai K, Kanakura Y, Hotta T.

Rinsho Ketsueki. 2016;57(11):2311-2318. Japanese.

PMID:
27941278
50.

Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment.

Kitahara H, Maruyama D, Maeshima AM, Makita S, Miyamoto KI, Fukuhara S, Munakata W, Suzuki T, Kobayashi Y, Tajima K, Terauchi T, Kurihara H, Taniguchi H, Komatsu N, Tobinai K.

Ann Hematol. 2017 Mar;96(3):411-420. doi: 10.1007/s00277-016-2891-8. Epub 2016 Dec 7.

PMID:
27928587

Supplemental Content

Loading ...
Support Center